Home

Přechod jít do práce Zalapání zucman rossi stefano caruso Požár mytologie Emulace

Loop | Jessica Zucman-Rossi
Loop | Jessica Zucman-Rossi

Study Points Toward New Ways to Prevent Liver Cancer | Mirage News
Study Points Toward New Ways to Prevent Liver Cancer | Mirage News

Stefano Caruso - Wikipedia
Stefano Caruso - Wikipedia

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

Cancers of the Liver ‐ Biology, Diagnosis and Treatment: Hepatology: Vol  73, No S1
Cancers of the Liver ‐ Biology, Diagnosis and Treatment: Hepatology: Vol 73, No S1

Germline and somatic DICER1 mutations in familial and sporadic liver tumors
Germline and somatic DICER1 mutations in familial and sporadic liver tumors

Our Research
Our Research

Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des  Cordeliers | Research profile
Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des Cordeliers | Research profile

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

MicroRNAs in Animal Models of HCC
MicroRNAs in Animal Models of HCC

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

The molecular road map of HCC
The molecular road map of HCC

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy  Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect

PPT - Disclosure PowerPoint Presentation, free download - ID:603758
PPT - Disclosure PowerPoint Presentation, free download - ID:603758

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as  first-line treatment for metastatic clear-cell renal cell carcinoma  (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised,  phase 2 trial - UROONCO Kidney Cancer
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer

The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting  FADD
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD

Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in  Hepatocellular Adenoma: Involvement of ERα and HNF1α
Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α

TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts  a poor prognosis in liver cancer - Archive ouverte HAL
TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer - Archive ouverte HAL

Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular  Diversity - Caruso - 2021 - Hepatology - Wiley Online Library
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity - Caruso - 2021 - Hepatology - Wiley Online Library

10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of  Hepatology.
10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of Hepatology.

BERENGERE OUINE | Institut Curie
BERENGERE OUINE | Institut Curie